In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)

Abroad (travel likely)Recruiting

Conditions

Chronic Lymphocytic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Wisconsin, Madison, Wisconsin, United States

Study leads

Christopher Fletcher, MD
Principal Investigator
School of Medicine and Public Health, University of Wisconsin, Madison

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma

Abroad (travel likely)Recruiting

Vancouver, Canada · Winnipeg, Canada

Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

Chronic Lymphocytic Leukemia (CLL) · Diffuse Large B-cell Lymphoma (DLBCL) · Follicular Lymphoma (FL)

Abroad (travel likely)Recruiting

Freiburg im Breisgau, Germany

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia · Small Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE3

Los Angeles, United States · Jupiter, United States